Athene Stock Price, News & Analysis (NYSE:ATH)

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Athene Holding Ltd (NYSE:ATH) issued its quarterly earnings results on Monday, August, 5th. The insurance provider reported $1.95 EPS for the quarter, topping the consensus estimate of $1.81 by $0.14. The insurance provider had revenue of $1.16 billion for the quarter, compared to analysts' expectations of $1.28 billion. Athene had a net margin of 16.27% and a return on equity of 12.84%. Athene's revenue for the quarter was up 21.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.48 earnings per share. View Athene's Earnings History.

Athene is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Athene.

Athene will be holding an earnings conference call on Tuesday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

11 brokers have issued 12-month price targets for Athene's shares. Their forecasts range from $47.00 to $68.00. On average, they anticipate Athene's share price to reach $54.89 in the next twelve months. This suggests a possible upside of 36.5% from the stock's current price. View Analyst Price Targets for Athene.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Athene in the last year. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Athene.

News stories about ATH stock have trended somewhat negative on Tuesday, InfoTrie reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Athene earned a coverage optimism score of -1.1 on InfoTrie's scale. They also assigned news coverage about the insurance provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Athene.

Athene saw a decrease in short interest in the month of September. As of September 30th, there was short interest totalling 3,410,000 shares, a decrease of 12.6% from the August 30th total of 3,900,000 shares. Based on an average daily volume of 1,370,000 shares, the short-interest ratio is currently 2.5 days. Approximately 2.4% of the company's stock are sold short. View Athene's Current Options Chain.

Some companies that are related to Athene include Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), AVIVA PLC/ADR (AVVIY), Legal & General Group (LGEN), Lincoln National (LNC), AEGON (AEG), Globe Life (GL), Reinsurance Group of America (RGA), SONY FINL HOLDI/ADR (SNYFY), Scor (SCRYY), Voya Financial (VOYA), Primerica (PRI), AMP (AMP), Brighthouse Financial (BHF) and American National Insurance (ANAT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include Alibaba Group (BABA), NVIDIA (NVDA), American Airlines Group (AAL), Amgen (AMGN), Baidu (BIDU), Intel (INTC), Micron Technology (MU), Allergan (AGN), Arista Networks (ANET) and Continental Resources (CLR).

(ATH) raised $952 million in an initial public offering (IPO) on Friday, December 9th 2016. The company issued 23,800,000 shares at $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities served as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

Athene's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Selz Capital LLC (0.31%), Artemis Investment Management LLP (0.12%), Gofen & Glossberg LLC IL (0.09%), Cerebellum GP LLC (0.01%) and Fox Run Management L.L.C. (0.00%). Company insiders that own Athene stock include Frank Lauren Gillis, Grant Kvalheim, Hope S Taitz, James Richard Belardi, Lawrence Ruisi, Manfred Puffer, Marc A Beilinson and Robert L Borden. View Institutional Ownership Trends for Athene.

ATH stock was sold by a variety of institutional investors in the last quarter, including Selz Capital LLC, Artemis Investment Management LLP and Gofen & Glossberg LLC IL. Company insiders that have sold Athene company stock in the last year include Frank Lauren Gillis, Lawrence Ruisi and Robert L Borden. View Insider Buying and Selling for Athene.

ATH stock was bought by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C. and Cerebellum GP LLC. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi and Marc A Beilinson. View Insider Buying and Selling for Athene.

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ATH stock can currently be purchased for approximately $40.21.

Athene has a market capitalization of $7.54 billion and generates $6.54 billion in revenue each year. The insurance provider earns $1.05 billion in net income (profit) each year or $5.82 on an earnings per share basis. Athene employs 1,275 workers across the globe.View Additional Information About Athene.

The official website for Athene is http://www.athene.com/.

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at 441-279-8400 or via email at [email protected]